Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CEO Kevin Charles Gorman sold 2,707 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $140.69, for a total value of $380,847.83. Following the transaction, the chief executive officer now owns 502,188 shares of the […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Forecasted to Post Q4 2023 Earnings of $1.17 Per Share themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Hussman Strategic Advisors Inc. lessened its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 22.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 28,400 shares of the company’s stock after selling 8,000 shares during the quarter. Hussman Strategic Advisors Inc.’s holdings […]
Barclays Boosts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences (NASDAQ:NBIX) Reaches New 52-Week High on Analyst Upgrade theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Rice Hall James & Associates LLC Sells 2,857 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Congress Asset Management Co. MA cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 26.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,229 shares of the company’s stock after selling 1,543 shares during the period. Congress Asset Management […]
Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Sells $14,016,787.40 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Mackenzie Financial Corp Boosts Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
California Public Employees Retirement System Reduces Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.